Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
The 7 Most Undervalued Long-Term Stocks to Buy Now
12:18pm, Wednesday, 19'th Oct 2022
My task today is to find seven of the most undervalued long-term stocks to buy now. We need to determine two things before stock selection takes place.
EMA recommends Moderna's new Omicron-tailored vaccine
11:26am, Wednesday, 19'th Oct 2022
The European Medical Agency on Wednesday recommended authorization of Moderna Inc's COVID-19 vaccine tailored towards targeting the Omicron sub-variants BA.4 and BA.5 for 12 and above ages.
Swiss to destroy 9 million expired Moderna COVID-19 jabs
10:55am, Wednesday, 19'th Oct 2022
Switzerland will destroy 9 million doses of Moderna COVID-19 vaccine that have reached their expiry date, with another 5.1 million vaccine jabs set to meet the same fate by February, the government sa
Moderna Stock Fails At Declining 50-Day Average; Check Out This Bearish Option Play
10:31am, Wednesday, 19'th Oct 2022
Traders who think Moderna stock will not reclaim the 50-day line could look at a bear call spread at 145-150. The post Moderna Stock Fails At Declining 50-Day Average; Check Out This Bearish Option Pl
Moderna CEO on COVID vaccines: Not everyone will need an annual COVID-19 booster
11:09pm, Tuesday, 18'th Oct 2022
Moderna CEO Stephane Bancel speaks with Anjalee Khemlani at Yahoo Finance's All Markets Summit about the COVID vaccine and why boosters will be necessary each year.
Why Moderna Stock Tripped and Fell on Tuesday
05:43pm, Tuesday, 18'th Oct 2022
The latest news about the coronavirus is encouraging, so the company's one commercialized product might not be such a popular item.
Will This News Send Moderna's Stock Soaring?
09:25am, Tuesday, 18'th Oct 2022
The company has been working on diversifying its pipeline.
Moderna CEO Stephane Bancel on the outlook for the extending timeline of mRNA technology efficacy
07:08am, Tuesday, 18'th Oct 2022
Moderna CEO Stephane Bancel spoke with Yahoo Finance on MRNA platform efficacy.
What the Smartest Investors Know About Moderna Stock
05:52am, Tuesday, 18'th Oct 2022
It's important to understand Moderna's near-term challenges and its long-term opportunities.
3 Growth Stocks That Could Soar 62.6% to 66.3%, According to Wall Street
05:31am, Tuesday, 18'th Oct 2022
Find out why analysts have such high hopes for these top growth stocks.
Moderna CEO Stephane Bancel talks business, vaccine demand, and medical advances
04:09pm, Monday, 17'th Oct 2022
Moderna CEO Stephane Bancel spoke with Yahoo Finance's Anjalee Khemlani at the 2022 Yahoo Finance All Markets Summit.
Moderna CEO: Merck deal ‘could be a game changer' for cancer treatment
04:07pm, Monday, 17'th Oct 2022
Moderna CEO Stéphane Bancel spoke with Anjalee Khemlani at Yahoo Finance's All Markets Summit about the company's deal with Merck to develop a cancer vaccine.
Moderna CEO: COVID-19 accelerated manufacturing network by 5 years
04:05pm, Monday, 17'th Oct 2022
Moderna CEO Stephane Bancel spoke with Anjalee Khemlani at Yahoo Finance's All Markets Summit about Moderna's manufacturing network and how it plays into what the company can now do.
Moderna CEO: Our global public health commitment 'is unconditional'
03:58pm, Monday, 17'th Oct 2022
Moderna CEO Stephane Bancel speaks at the All Markets Summit about the company's commitment to providing COVID-19 vaccines for low- and middle-income countries.
Moderna, Gavi cancel COVID-19 vaccine orders for rest of 2022 due to 'sufficient supply'
06:13am, Monday, 17'th Oct 2022
Moderna Inc. MRNA, -0.53% said it and GAVI, the Vaccine Alliance supplying vaccines to low- and middle-income countries, have agreed to cancel remaining orders under their 2022 COVID-19 vaccine agreem
